|
1）Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer; a single-institution experience. J Gastrointest Surg. 2006; 10: 1199-210
|
|
|
|
2）日本膵臓学会，膵癌診療ガイドライン改訂委員会，編．科学的根拠に基づく膵癌診療ガイドライン．2013年版．東京: 金原出版; 2013
|
|
|
|
|
|
3）田中雅夫，編．膵癌登録報告2007．膵臓．2007; 22: e1-e427
|
|
|
|
|
4）Sa Cunha A, Rault A, Laurent C, et al. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas. J Am Coll Surg. 2005; 201: 359-65
|
|
|
|
|
|
5）Reddy SK, Tyler DS, Pappas TN, et al. Extended resection for pancreatic adenocarcinoma. Oncologist. 2007; 12: 654-63
|
|
|
|
|
|
6）Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part2; randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002; 236: 355-66
|
|
|
|
|
|
7）Jan JY, Kang MJ, Heo JS, et al. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer. Ann Surg. 2014; 259: 656-64
|
|
|
|
|
|
8）Ishikawa O, Ohigashi H, Teshima T, et al. Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreatoduodenal region. J Surg Oncol. 1989; 40: 143-51
|
|
|
|
|
|
9）Yeung RS, Weese JL, Hoffman JP, et al. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. Cancer. 1993; 72: 2124-33
|
|
|
|
|
|
10）Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Borderline resectable pancreatic cancer; definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006; 13: 1035-46
|
|
|
|
|
|
11）Assifi MM, Lu X, Eibl G, et al. Neoadjuvant therapy in pancreatic adenocarcinoma; a meta-analysis of phase II trials. Surgery. 2011; 150: 466-73
|
|
|
|
|
|
12）NCCNガイドライン．日本語版．膵腺癌．http://www.tri-kobe.org/nccn/guideline/pancreas/japanese/pancreatic.pdf
|
|
|
|
|
|
14）Kosuge T, Sakamoto Y, Ueno H. Postoperative adjuvant therapy. J Hepatobiliary Pancreat Sci. 2011; 18: 792-6
|
|
|
|
|
|
15）Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer; a randomized controlled trial. JAMA. 2007; 297: 267-77
|
|
|
|
|
|
16）Ueno H, Kosuge T, Matsuyama Y, et al. A randomized phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer; Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer. 2009; 101: 908-15
|
|
|
|
|
|
17）江川新一，武田和憲，福山尚治，他．わが国の膵癌全国調査から．肝・胆・膵．2003; 46: 683-96
|
|
|
|
|
|
18）Uesaka F, Fukutomi A, Boku N, et al. Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 for patients with resected pancreatic cancer (JASPAC-01 study). J Clin Oncol 30 [Suppl 34]: abstract 145, 2012
|
|
|
|
|
|
19）Takahashi S, Kinoshita T, Konishi M, et al. Borderline resectable pancreatic cancer; rationale for multidisciplinary treatment. J Hepatobiliary Pancreat Sci. 2011; 18: 567-74
|
|
|
|
|
|
20）吉富秀幸，清水宏明，大塚将之，他．がん種別の治療指針 膵癌 最近の話題と今後の課題．臨外．2014; 69: 1364-70
|
|
|
|
|
21）Nakao A, Kanzaki A, Fujii T, et al. Correlation between radiographic classification and pathological grade of portal vein well invasion in pancreatic head cancer. Ann Surg. 2012; 255: 103-8
|
|
|
|
|
|
22）Kanda M, Fujii T, Suenaga M, et al. Pancreatoduodenectomy with portal vein resection is feasible and potentially beneficial for elderly patients with pancreatic cancer. Pancreas. 2014; 43: 951-8
|
|
|
|
|
|
23）Ravikumar R, Sabin C, Abu Hilal M, et al. Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study. J Am Coll Surg. 2014; 218: 401-11
|
|
|
|
|
|
24）Murakami Y, Satoi S, Motoi F, et al. Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma. Br J Surg. 2015; 102: 837-46
|
|
|
|
|
|
25）Nakao A, Takeda S, Inoue S, et al. Indications and techniques of extended resection for pancreatic cancer. World J Surg. 2006; 30: 976-82
|
|
|
|
|
|
26）Backhorn M, Burdelski C, Bogoevski D, et al. Arterial en bloc resection for pancreatic carcinoma. Br J Surg. 2011; 98: 86-92
|
|
|
|
|
|
27）Amano H, Miura F, Toyota N, et al. Is pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer? J Hepatobiliary Pancreat Surg. 2009; 16: 850-7
|
|
|
|
|
|
28）Mollberg N, Rahbari NN, Koch M, et al. Arterial resection during pancreatectomy for pancreatic cancer. A systematic review and meta-analysis. Ann Surg. 2011; 254: 882-93
|
|
|
|
|
|
29）Bachellier P, Rosso E, Lucescu I, et al. Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study. J Surg Oncol. 2011; 103: 75-84
|
|
|
|
|
|
30）Christians KK, Pilgrim CHC, Tsai S, et al. Arterial resection at the time of pancreatectomy for cancer. Surgery. 2014; 155: 919-26
|
|
|
|
|
|
31）Hirano S, Kondo S, Hara T, et al. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer; long-term results. Ann Surg. 2007; 246: 46-51
|
|
|
|
|
|
32）Kondo S, Katoh H, Hirano S, et al. Results of radical distal pancreatectomy with en bloc resection of the celiac artery for locally advanced cancer of the pancreatic body. Langenbecks Arch Surg. 2003; 388: 101-6
|
|
|
|
|
|
33）Miura T, Hirano S, Nakamura T, et al. A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection; a retrospective cohort study. Surgery. 2014; 155: 457-67
|
|
|
|
|
|
34）Kimura A, Yamamoto J, Aosasa S, et al. Importance of maintaining left gastric arterial flow at Appleby operation preserving whole stomach for central pancreatic cancer. Hepatogastroenterology. 2012; 59: 2650-2
|
|
|
|
|
|
35）Okada K, Kawai M, Tani M, et al. Presevation of the left gastric artery on the basis of anatomical features in patients undergoing distal pancreatectomy with celiac axis en-bloc resection (DP-CAR). World J Surg. 2014; 38: 2980-5
|
|
|
|
|
|
36）Desaki R, Mizuno S, Tanemura A, et al. A new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma of the pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreatectomy. Biomed Res Int. 2014; 2014: 1-14
|
|
|
|
|
|
37）Yoshidome H, Shimizu H, Otsuka M, et al. Pancreaticoduodenetomy combined with hepatic artery resection following preoperative hepatic arterial embolization. J Hepatobiliary Pancreat Sci. 2014; 21: 850-5
|
|
|
|
|